Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Clinical Rheumatology
|
July 28, 2004
Autoimmune manifestations in common variable immunodeficiency
Stavroula Giannouli, Dimitra Anagnostou, Fotini Soliotis, et al.
Leukemia Research
|
April 11, 2007
A unique case of IgD-only splenic marginal-zone lymphoma with mutated immunoglobulin genes: ontogenetic implications
Theodora Papadaki, Kostas Stamatopoulos, Theodore Mavrommatis, et al.
American Journal of Hematology
|
September 27, 2005
Myelofibrosis-associated massive splenomegaly: a cause of increased intra-abdominal pressure, pulmonary hypertension, and positional dyspnea
Panayiotis D Ziakas, Michael Voulgarelis, Evagelos Felekouras, et al.
Leukemia & Lymphoma
|
December 3, 2005
Extranodal non-Hodgkin's lymphoma presenting as an abdominal wall mass. A case report and review of the literature
George Bozas, Dimitra Anagnostou, Anna Tassidou, et al.
Leukemia & Lymphoma
|
April 6, 2004
Discordant response or progression in patients with myeloma treated with thalidomide-based regimens
Athanasios Anagnostopoulos, George Hamilos, Markela P Zorzou, et al.
Digestive Diseases and Sciences
|
September 1, 2005
Molecular analysis of B-cell clonality in Helicobacter pylori gastritis
Sotirios D Georgopoulos, Konstantinos Triantafyllou, Maria Fameli, et al.
The American Journal of Surgical Pathology
|
February 28, 2007
Splenic marginal-zone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases
Theodora Papadaki, Kostas Stamatopoulos, Chrysoula Belessi, et al.
American Journal of Hematology
|
May 9, 2012
Increased expression of cyclin-D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agents
Anna Tasidou, Maria Roussou, Evangelos Terpos, et al.
Leukemia & Lymphoma
|
October 30, 2004
Treatment of relapsed/refractory multiple myeloma with thalidomide-based regimens: identification of prognostic factors
Athanasios Anagnostopoulos, Dimitra Gika, George Hamilos, et al.
Molecular Medicine (Cambridge, Mass.)
|
February 12, 2005
Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma
Kostas Stamatopoulos, Chrysoula Belessi, Theodora Papadaki, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Clinical Rheumatology
|
July 28, 2004
Autoimmune manifestations in common variable immunodeficiency
Stavroula Giannouli, Dimitra Anagnostou, Fotini Soliotis, et al.
Leukemia Research
|
April 11, 2007
A unique case of IgD-only splenic marginal-zone lymphoma with mutated immunoglobulin genes: ontogenetic implications
Theodora Papadaki, Kostas Stamatopoulos, Theodore Mavrommatis, et al.
American Journal of Hematology
|
September 27, 2005
Myelofibrosis-associated massive splenomegaly: a cause of increased intra-abdominal pressure, pulmonary hypertension, and positional dyspnea
Panayiotis D Ziakas, Michael Voulgarelis, Evagelos Felekouras, et al.
Leukemia & Lymphoma
|
December 3, 2005
Extranodal non-Hodgkin's lymphoma presenting as an abdominal wall mass. A case report and review of the literature
George Bozas, Dimitra Anagnostou, Anna Tassidou, et al.
Leukemia & Lymphoma
|
April 6, 2004
Discordant response or progression in patients with myeloma treated with thalidomide-based regimens
Athanasios Anagnostopoulos, George Hamilos, Markela P Zorzou, et al.
Digestive Diseases and Sciences
|
September 1, 2005
Molecular analysis of B-cell clonality in Helicobacter pylori gastritis
Sotirios D Georgopoulos, Konstantinos Triantafyllou, Maria Fameli, et al.
The American Journal of Surgical Pathology
|
February 28, 2007
Splenic marginal-zone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases
Theodora Papadaki, Kostas Stamatopoulos, Chrysoula Belessi, et al.
American Journal of Hematology
|
May 9, 2012
Increased expression of cyclin-D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agents
Anna Tasidou, Maria Roussou, Evangelos Terpos, et al.
Leukemia & Lymphoma
|
October 30, 2004
Treatment of relapsed/refractory multiple myeloma with thalidomide-based regimens: identification of prognostic factors
Athanasios Anagnostopoulos, Dimitra Gika, George Hamilos, et al.
Molecular Medicine (Cambridge, Mass.)
|
February 12, 2005
Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma
Kostas Stamatopoulos, Chrysoula Belessi, Theodora Papadaki, et al.
Page
of 2